SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 18.09 |
| Enterprise Value ($M) | -20.31 |
| Book Value ($M) | 54.18 |
| Book Value / Share | 6.41 |
| Price / Book | 0.33 |
| NCAV ($M) | 44.33 |
| NCAV / Share | 5.24 |
| Price / NCAV | 0.41 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.02 |
| Return on Assets (ROA) | -0.01 |
| Return on Equity (ROE) | -0.01 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 27.34 |
| Current Ratio | 27.34 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 61.51 |
| Assets | 71.36 |
| Liabilities | 17.18 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Ayrton Capital LLC | 9.90 | -45.38 | |
| 13G/A | Intracoastal Capital, Llc | 9.99 | -52.92 | |
| 13D/A | Iroquois Capital Management, LLC | 4.99 | -84.76 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 2 | 5,601 | 0.04 | |
| 5,019 | 14,464 | 34.70 | |
| 364 | 627 | 58.05 | |
| 11 | 426 | 2.58 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PHIO – Phio Pharmaceuticals Corp. | PIRS – Pieris Pharmaceuticals, Inc. |
| PLUR – Pluri Inc. | PMGM – Priveterra Acquisition Corp. II |
| PMN – ProMIS Neurosciences, Inc. |
Financial data and stock pages provided by
Fintel.io